All stock lists
Accuray Inc (ARAY)
NASDAQ: ARAY · Real-Time Price · USD
Healthcare · Medical Devices
0.12-0.01 (-4.61%)
Market cap
$14.8M
Website
Insider Score
––Not scored
ARAY Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
ARAY analyst forecast
Best analysts covering ARAY
- BTIG50%success rate · 2 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
ARAY analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Jefferies | Hold | — | — | Downgraded | 2026-05-12 |
| — | BTIG | Neutral | — | — | Downgraded | 2026-05-07 |
| — | BTIG | Buy | — | — | Reiterated | 2026-02-05 |
| — | BTIG | Buy | — | — | Reiterated | 2025-11-06 |
| — | BTIG | Buy | — | — | Reiterated | 2025-08-14 |
| — | B. Riley Securities | Buy | — | — | Reiterated | 2023-10-04 |
| — | B. Riley Securities | Buy | — | — | Reiterated | 2022-08-31 |
| — | BTIG | Buy | — | — | Reiterated | 2022-06-24 |
| — | B. Riley Securities | Buy | — | — | Reiterated | 2022-06-23 |
| — | Loop Capital | Buy | — | — | Reiterated | 2021-12-22 |
| — | BTIG | Buy | — | — | Upgraded | 2020-01-21 |
| — | BTIG Research | Buy | — | — | Upgraded | 2020-01-21 |
| — | Citigroup | Neutral | — | — | Upgraded | 2018-11-01 |
| — | Citigroup | Sell | — | — | Reiterated | 2018-08-17 |
| — | JP Morgan | Underweight | — | — | Downgraded | 2017-12-19 |
| — | JP Morgan | Underweight | — | — | Downgraded | 2017-12-13 |
| — | Lake Street | Buy | — | — | Reiterated | 2017-11-30 |
| — | Jefferies | Buy | — | — | Reiterated | 2017-08-23 |
| — | Aegis Capital | Buy | — | — | Reiterated | 2017-02-06 |
| — | JP Morgan | Neutral | — | — | Downgraded | 2016-12-14 |
| — | Cowen & Co. | Outperform | — | — | Reiterated | 2016-09-13 |
| — | RBC Capital | Perform | — | — | Reiterated | 2015-12-22 |
| — | Citigroup | Sell | — | — | Reiterated | 2015-11-12 |
| — | Northland Securities | Outperform | — | — | Reiterated | 2015-01-12 |
| — | JP Morgan | Overweight | — | — | Upgraded | 2014-06-13 |
| — | BTIG Research | Buy | — | — | Reiterated | 2014-03-11 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2014-01-31 |
| — | JP Morgan | Neutral | — | — | Upgraded | 2013-09-20 |
| — | Jefferies | Buy | — | — | Reiterated | 2013-08-28 |
| — | JP Morgan | Underweight | — | — | Downgraded | 2013-01-04 |
| — | Jefferies | Buy | — | — | Reiterated | 2013-01-04 |
| — | Brean Capital | Buy | — | — | Reiterated | 2012-10-26 |
| — | Jefferies | Buy | — | — | Reiterated | 2012-10-09 |
| — | Jefferies | Buy | — | — | Reiterated | 2012-09-07 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2012-02-09 |
ARAY earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-04 | -0.11 | -0.11 | $100.9M | $102.2M |
| 2026-05-06 | -0.05 | -0.09 | $111.9M | $104.8M |
| 2026-08-19 | -0.03 | -0.02 | $105.3M | $100.9M |
| 2026-11-04 | -0.07 | 0.00 | $95.8M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.